Royal Bank of Canada’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$45.3M Sell
525,419
-39,063
-7% -$3.51M 0.01% 961
2025
Q4
$49.3M Sell
564,482
-428,638
-43% -$32.5M 0.01% 950
2025
Q3
$56.9M Sell
993,120
-168,501
-15% -$9.7M 0.01% 947
2025
Q2
$68.6M Buy
1,161,621
+744,832
+179% +$48.1M 0.01% 783
2025
Q1
$30.5M Buy
416,789
+56,432
+16% +$4.66M 0.01% 1048
2024
Q4
$29.8M Sell
360,357
-419,957
-54% -$33.1M 0.01% 1101
2024
Q3
$55.8M Buy
780,314
+5,614
+0.7% +$396K 0.01% 772
2024
Q2
$53.1M Buy
774,700
+88,674
+13% +$5.3M 0.01% 750
2024
Q1
$36.8M Sell
686,026
-117,432
-15% -$6.31M 0.01% 919
2023
Q4
$42.8M Buy
803,458
+308,435
+62% +$15M 0.01% 848
2023
Q3
$24.6M Buy
495,023
+293,713
+146% +$16.4M 0.01% 1047
2023
Q2
$12M Buy
201,310
+16,227
+9% +$925K ﹤0.01% 1464
2023
Q1
$10.5M Sell
185,083
-172,691
-48% -$11.1M ﹤0.01% 1522
2022
Q4
$26.6M Buy
357,774
+59,434
+20% +$4.05M 0.01% 987
2022
Q3
$17.8M Buy
298,340
+1,681
+0.6% +$101K 0.01% 1136
2022
Q2
$16.7M Sell
296,659
-50,605
-15% -$3.33M ﹤0.01% 1225
2022
Q1
$25.6M Sell
347,264
-16,591
-5% -$1.15M 0.01% 1093
2021
Q4
$26.3M Sell
363,855
-65,042
-15% -$4.72M 0.01% 1219
2021
Q3
$32.9M Sell
428,897
-32,017
-7% -$2.57M 0.01% 993
2021
Q2
$35.7M Buy
460,914
+6,488
+1% +$461K 0.01% 941
2021
Q1
$28M Sell
454,426
-29,990
-6% -$1.9M 0.01% 1062
2020
Q4
$31.6M Buy
484,416
+17,324
+4% +$996K 0.01% 947
2020
Q3
$23.1M Sell
467,092
-63,714
-12% -$3.29M 0.01% 999
2020
Q2
$25.3M Sell
530,806
-54,961
-9% -$2.65M 0.01% 917
2020
Q1
$24.9M Buy
585,767
+1,545
+0.3% +$76.3K 0.01% 784
2019
Q4
$34.4M Sell
584,222
-81,453
-12% -$4.42M 0.01% 811
2019
Q3
$34M Sell
665,675
-56,986
-8% -$2.71M 0.01% 761
2019
Q2
$30.6M Sell
722,661
-57,721
-7% -$2.51M 0.01% 833
2019
Q1
$38.6M Sell
780,382
-37,562
-5% -$1.7M 0.02% 680
2018
Q4
$35.4M Sell
817,944
-255,933
-24% -$12.8M 0.02% 674
2018
Q3
$61M Sell
1,073,877
-43,887
-4% -$2.31M 0.03% 503
2018
Q2
$56.4M Sell
1,117,764
-162,879
-13% -$8.49M 0.03% 507
2018
Q1
$63.8M Sell
1,280,643
-20,901
-2% -$982K 0.03% 482
2017
Q4
$53.5M Sell
1,301,544
-34,796
-3% -$1.22M 0.02% 569
2017
Q3
$39.7M Buy
1,336,340
+77,046
+6% +$2.35M 0.02% 678
2017
Q2
$41.7M Sell
1,259,294
-45,830
-4% -$1.44M 0.02% 626
2017
Q1
$38.7M Buy
1,305,124
+311,796
+31% +$8.51M 0.02% 641
2016
Q4
$24.6M Buy
993,328
+19,344
+2% +$440K 0.01% 915
2016
Q3
$22M Buy
973,984
+665,540
+216% +$15.6M 0.01% 954
2016
Q2
$7.35M Buy
308,444
+44,924
+17% +$1.08M ﹤0.01% 1652
2016
Q1
$6.26M Buy
263,520
+254,275
+2,750% +$6.22M ﹤0.01% 1673
2015
Q4
$257K Sell
9,245
-15,311
-62% -$384K ﹤0.01% 4344
2015
Q3
$508K Buy
24,556
+16,838
+218% +$426K ﹤0.01% 3482
2015
Q2
$198K Buy
7,718
+6,130
+386% +$155K ﹤0.01% 4371
2015
Q1
$41K Sell
1,588
-902
-36% -$22K ﹤0.01% 5062
2014
Q4
$59K Sell
2,490
-19,069
-88% -$422K ﹤0.01% 4981
2014
Q3
$424K Buy
21,559
+21,345
+9,974% +$439K ﹤0.01% 3626
2014
Q2
$5K Hold
214
﹤0.01% 5560
2014
Q1
$6K Hold
214
﹤0.01% 5539
2013
Q4
$4K Sell
214
-1,641
-88% -$30.5K ﹤0.01% 5642
2013
Q3
$32K Buy
+1,855
New +$32.1K ﹤0.01% 4998

Other funds holding GMED

Royal Bank of Canada's GMED Position: Q1 2026 in Review

Royal Bank of Canada reduced its Globus Medical (GMED) stake by 6.9% in Q1 2026, selling an estimated $3.51M and leaving 525,419 shares worth $45.3M. The position accounts for 0.01% of the portfolio, ranked #961.

Royal Bank of Canada first reported a position in GMED in Q3 2013 and has held it in 51 quarters since. The position peaked at $68.6M in Q2 2025. 603 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Royal Bank of Canada held 525,419 shares of Globus Medical worth $45.3M as of Q1 2026.
  • Royal Bank of Canada sold 39,063 Globus Medical shares in Q1 2026, an estimated $3.51M.
  • Globus Medical made up 0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #961 holding.
  • Royal Bank of Canada first reported a position in Globus Medical in Q3 2013 and has held it in 51 quarters since.
  • Royal Bank of Canada's Globus Medical position peaked at $68.6M in Q2 2025.
  • 603 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.